Copyright
©2010 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Sep 16, 2010; 2(9): 301-304
Published online Sep 16, 2010. doi: 10.4253/wjge.v2.i9.301
Published online Sep 16, 2010. doi: 10.4253/wjge.v2.i9.301
Table 1 Natural courses studies of low and high grade dysplasia progressing to carcinoma
| Low grade dysplasia | Mean interval to carcinoma | High grade dysplasia | Mean interval to carcinoma | |
| Saraga et al[19] | 2% (1/64) | 4 yr | 81% (7/21) | 4 mo |
| Lansdown et al[20] | 0% (0/7) | - | 85% (11/13) | 5 mo |
| Di Gregorio et al[21] | 7% (4/73) | 2 yr | 60% (6/10) | 11 mo |
| Kokkola et al[22] | 0% (0/84) | - | 67% (2/3) | 1.5 yr |
| Rugge et al[11] | 8.9% (8/90) | 48 mo | 69% (11/16) | 30 mo |
| Yamada et al[12] | 0% (0/38) | - | 10% (1/10) | 4.6 yr |
| Park et al[13] | 11.5% (3/26) | 3.7 yr | 100% (1/1) | 5.6 yr |
- Citation: Jeon SW. Endoscopic management of gastric dysplasia: Cutting edge technology needs a new paradigm. World J Gastrointest Endosc 2010; 2(9): 301-304
- URL: https://www.wjgnet.com/1948-5190/full/v2/i9/301.htm
- DOI: https://dx.doi.org/10.4253/wjge.v2.i9.301